Abstract：Objective To study the clinical significance of SDC2 in non small cell lung cancer (NSCLC). Methods The surgical resections of NSCLC tissues of 73 cases were collected in the First Hospital of Qinhuangdao City in Hebei Province from January 2015 to January 2017 as NSCLC group. The expression of SDC2 was masured by IHC staining of NSCLC compared with normal tissue adjacent to cancer (control group). Results Compared with control group, the positive expression of SDC2 was increased in NSCLC and had a realtionship with cancer differentation and TNM stages (P < 0.05). Conclusion SDC2 may be one of potentail targets for dignosis and treatment of NSCLC.
[1] Rosell R，Karachaliou N. Large-scale screening for somatic mutations in lung cancer [J]. Lancet，2016，387（10026）：1354-1356.
[2] Cho BC，DE Pas T，Kalofonos H，et al. Prognostic factors in early-stage NSCLC：analysis of the placebo group in the MAGRIT study [J]. Anticancer Res，2019，39（3）：1403-1409.
[3] Pataki CA，Couchman JR，Brábek J. Wnt signaling cascades and the roles of syndecan proteoglycans [J]. J Histochem Cytochem，2015，63（7）：465-480.
[4] Kramer KL，Yost HJ. Heparan sulfate core proteins in cell-cell signaling [J]. Annu Rev Gene，2003，37：461-484.
[5] Mytilinaiou M，Nikitovic D，Berdiaki A，et al. Emerging roles of syndecan 2 in epithelial and mesenchymal cancer progression [J]. IUBMB Life，2017，69（11）：824-833.
[6] Vicente CM，Ricci R，Nader HB，et al. Syndecan-2 is upregulated in colorectal cancer cells through interactions with extracellular matrix produced by stromal fibroblasts [J]. BMC Cell Biol，2013，14：25.
[7] Jang B，Jung H，Chung H，et al. Syndecan-2 enhances E-cadherin shedding and fibroblast-like morphological changes by inducing MMP-7 expression in colon cancer cells [J]. Biochem Biophys Res Commun，2016，477（1）：47-53.
[8] Popovi■ A，Demirovi■ A，Spaji■ B，et al. Expression and prognostic role of syndecan-2 in prostate cancer [J]. Prostate Cancer Prostatic Dis，2010，13（1）：78-82.
[9] Sun M，Gomes S，Chen P，et al. RKIP and HMGA2 regulate breast tumor survival and metastasis through lysyl oxidase and syndecan-2 [J]. Oncogene，2014，33（27）：3528-3537.
[10] Huang X，Xiao DW，Xu LY，et al. Prognostic significance of altered expression of SDC2 and CYR61 in esophageal squamous cell carcinoma [J]. Oncol Rep，2009，21（4）：1123-1129.
[11] Wan Y，Belt A，Wang Z，et al. Transmodulation of epidermal growth factor receptor mediates IL-1 beta-induced MMP-1 expression in cultured human keratinocytes [J]. Int J Mol Med，2001，7（3）：329-334.
[12] Mytilinaiou M，Nikitovic D，Berdiaki A，et al. IGF-I regulates HT1080 fibrosarcoma cell migration through a syndecan-2/Erk/ezrin signaling axis [J]. Exp Cell Res，2017，361（1）：9-18.
[13] Huang JW，Chen CL，Chuang NN. P120-GAP associated with syndecan-2 to function as an active switch signal for Src upon transformation with oncogenic ras [J]. Biochem Biophys Res Commun，2005，329（3）：855-862.
[14] Lee YH，Park JH，Cheon DH，et al. Processing of syndecan-2 by matrix metalloproteinase-14 and effect of its cleavage on VEGF-induced tube formation of HUVECs [J]. Biochem J，2017，474（22）：3719-3732.
[15] Liu Y，Ni R，Zhang H，et al. Identification of feature genes for smoking-related lung adenocarcinoma based on gene expression profile data [J]. Onco Targets Ther，2016，9：7397-7407.
[16] Li TT，Gao X，Gao L，et al. Role of upregulated miR-136-5p in lung adenocarcinoma：a study of 1242 samples utilizing bioinformatics analysis [J]. Pathol Res Pract，2018，214（5）：750-766.
[17] Jang B，Jung H，Choi S，et al. Syndecan-2 cytoplasmic domain up-regulates matrix metalloproteinase-7 expression via the protein kinase Cγ-mediated FAK/ERK signaling pathway in colon cancer [J]. J Biol Chem，2017， 292（39）：16321-16332.
[18] Mytilinaiou M，Bano A，Nikitovic D，et al. Syndecan-2 is a key regulator of transforming growth factor beta 2/smad2-mediated adhesion in fibrosarcoma cells [J]. IUBMB Life，2013，65（2）：134-143.
[19] Yang X，Deng Y，He RQ，et al. Upregulation of HOXA11 during the progression of lung adenocarcinoma detected via multiple approaches [J]. Int J Mol Med，2018，42（5）：2650-2664.
[20] Zhao F，Pu Y，Cui M，et al. MiR-20a-5p represses the multi-drug resistance of osteosarcoma by targeting the SDC2 gene [J]. Cancer Cell Int，2017，17：100.
[21] Cai X，Yang X，Jin C，et al. Identification and verification of differentially expressed microRNAs and their target genes for the diagnosis of esophageal cancer [J]. Oncol Lett，2018，16（3）：3642-3650.
[22] Park YS，Kim DS，Cho SW，et al. Analysis of syndecan-2 methylation in bowel lavage fluid for the detection of colorectal neoplasm [J]. Gut Liver，2018，12（5）：508-515.
[23] Niu F，Wen J，Fu X，et al. Stool DNA test of methylated syndecan-2 for the early detection of colorectal neoplasia [J]. Cancer Epidemiol Biomarkers Prev，2017，26（9）：1411-1419.
2019, Vol. 16 
京公网安备 11010502046598号